ACC Media Center
@ACCmediacenter
The latest news from the American College of Cardiology (ACC) and the 🌎 of cardiovascular health. Follow @ACCinTouch for other ACC updates.
ID:23995096
http://www.acc.org/mediacenter 12-03-2009 18:07:20
13,6K Tweets
20,7K Followers
1,1K Following
Follow People
👵👵🏽👵🏿👵🏻 TCTMD reports, “Maintaining a systolic blood pressure below 130 mm Hg may increase the probability of survival to age 90 in healthy older women, with or without BP-lowering medications, data from the WHI suggest.” bit.ly/49Y8jDE LA McKeown #hypertension
Age-related somatic mutations tied to CV death among patients with subclinical #atherosclerosis , #JACC study finds. Nicole Lou reports for MedPage Today: bit.ly/3UjZOwI #cvGeri #CVD
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine
📰 Cardiovascular Business: bit.ly/3UBBQ1n
#CVBoard #Cardiology
A study presented at #ACC24 found 'people who vape are nearly 20% more at risk of heart failure than non-vapers,' reports Yahoo Life UK. bit.ly/4aSMmqQ #cvPrev #smoking #heartfailure
📰 📽️ Cardiovascular Business looks at how ACC doubled the number of business-related sessions at #ACC24 as economics and business finance literacy are more important than ever as reimbursements continue to decline. Hear from session co-chair Alison L. Bailey, MD: bit.ly/3U8UAE0
A new study found that self-selection for a #Stain using a web tool is safe and effective. These findings were presented at #ACC24 and published in #JACC . Find out more in MedPage Today with Crystal Phend: bit.ly/3JxO70v
There is a high prevalence of unrecognized #HeartDisease among retired 🏈 NFL players, according to a study presented at #ACC24 and simultaneously published in #JACC . Get the details in Cardiology Today: bit.ly/3xP2WJD
A study presented at #ACC24 found that a CSR implant lead to symptom relief for people with stable #cvCAD & refractory angina. Learn more about the ORBITA-COSMIC trial in MedPage Today: bit.ly/3WeEN9u Nicole Lou
Plozasiran decreased triglycerides, ApoC-III and non-HDL for patients w/ severe hypertriglyceridemia, according to the SHASTA-2 trial presented at #ACC24 . bit.ly/3xWFCta Cardiology Today Scott Buzby